WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2014186982) USE OF DENCICHINE IN PREPARATION OF DRUG FOR TREATING THROMBOCYTOPENIA
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2014/186982    International Application No.:    PCT/CN2013/076216
Publication Date: 27.11.2014 International Filing Date: 24.05.2013
IPC:
A61K 31/198 (2006.01), A61K 9/00 (2006.01), A61P 7/04 (2006.01), A61P 35/00 (2006.01), A61P 31/06 (2006.01)
Applicants: KUNMING SHENGHUO PHARMACEUTICAL (GROUP) CO., LTD. [CN/CN]; No. 2, Jing You Road, National Economy and Technology Development Area Kunming, Yunnan 650217 (CN)
Inventors: LAN, Guihua; (CN).
LAN, Feng; (CN).
SUN, Xiaobo; (CN)
Agent: SUNSHINE INTELLECTUAL PROPERTY INTERNATIONAL CO., LTD.; Room 503, Floor 5, Tower A, Zhongguancun Intellectual Property Building No.21, A, Haidian South Road, Haidian District Beijing 100080 (CN)
Priority Data:
Title (EN) USE OF DENCICHINE IN PREPARATION OF DRUG FOR TREATING THROMBOCYTOPENIA
(FR) UTILISATION DE DENCICHINE DANS LA PRÉPARATION D'UN MÉDICAMENT POUR LE TRAITEMENT DE LA THROMBOCYTOPÉNIE
(ZH) 三七素在制备治疗血小板减少症的药物的应用
Abstract: front page image
(EN)Disclosed are uses of drugs for treating thrombocytopenia, in particular the use of dencichine in preparation of drugs for treating thrombocytopenia. By adding pharmaceutically acceptable conventional adjuvant material, dencichine can be prepared into an oral preparation or an injection. A pharmacodynamic trial shows that the dencichine can effectively inhibit the thrombocytopenia caused by chemotherapy drugs, and treat thrombocytopenic purpura with obvious curative effect and low toxic side effects.
(FR)La présente invention concerne des utilisations de médicaments pour le traitement de la thrombocytopénie, en particulier l'utilisation de dencichine dans la préparation de médicaments pour le traitement de la thrombocytopénie. L'addition d'une substance adjuvante pharmaceutiquement acceptable classique permet de préparer de la dencichine en préparation orale ou en injection. Selon l'invention, un essai pharmacodynamique montre que la dencichine peut inhiber efficacement la thrombocytopénie provoquée par des médicaments de chimiothérapie, et traiter le purpura thrombocytopénique avec un effet curatif évident et peu d'effets secondaires toxiques.
(ZH)本发明涉及一种治疗血小板减少症的药物的用途,具体涉及三七素在制备治疗血小板减少症的药物的应用。可通过添加药学上可接受的常规辅料,将三七素制备成口服制剂或注射制剂。药效学试验表明三七素能有效抑制因化疗药物导致的血小板减少和血小板减少性紫癜的治疗,疗效显著,毒副作用小。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)